Immunhistochemical expression of galectin-3 in cancer: A review of the literature;Kanser vakalarında i̇mmünohistokimyasal galektin-3 ekspresyonu: Literatür taraması

Turk Patoloji Dergisi/Turkish Journal of Pathology

Volumn 28, Issue 1, 2012, Pages 1-10

  Çay, Tuǧçe ^a  

^a NONE

Author keywords

Cancer; Galectin 3; Immunohistochemistry

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CORTICOTROPIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYTOKERATIN 19; GALECTIN 3; GALECTIN 7; GALECTIN 8; PROLACTIN; PROTEIN KINASE PIM 1; PROTEIN P21;

ANGIOGENESIS; APOPTOSIS; ARTICLE; ASTROCYTOMA; BREAST TUMOR; CANCER SURVIVAL; CARCINOGENESIS; CELL ADHESION; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM TUMOR; CLEAR CELL CARCINOMA; COLORECTAL CANCER; DOWN REGULATION; EMBRYO DEVELOPMENT; ENDOCRINE TUMOR; ENDOMETRIOSIS; EOSINOPHIL; FEMALE GENITAL TRACT TUMOR; GALLBLADDER TUMOR; GASTROINTESTINAL TUMOR; HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CANCER; LYMPH NODE METASTASIS; MACROPHAGE; MAST CELL; METASTASIS; NEOPLASM; NEUTROPHIL; PARATHYROID CARCINOMA; POSTERIOR CRANIAL FOSSA TUMOR; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT TUMOR; RNA SPLICING; SENSITIVITY AND SPECIFICITY; STOMACH CARCINOMA; SURVIVAL RATE; UPREGULATION; URINARY TRACT TUMOR;

EID: 84855753234     PISSN: 10185615     EISSN: 13095730     Source Type: Journal    
DOI: 10.5146/tjpath.2012.01090     Document Type: Article

References (58)

1. Lee J, Moon C, Kim J, Jung C, Lee KH, Joo HG, Ahn M, Shin T: Immunohistochemical localization of galectin-3 in the granulomatous lesions of paratuberculosis-infected bovine intestine. J Vet Sci 2009, 10:177-180
2. Yi Wang, Pratima Nangia-Makker, Larry Tait, Vitaly Balan, Victor Hogan, Kenneth J. Pienta, Avraham Raz: Regulation of Prostate Cancer Progressionby Galectin-3. Am J Pathol 2009, 174:1515-1523
3. Sakaki M, Fukumori T, Fukawa T, Elsamman E, Shiirevnyamba A, Nakatsuji H, Kanayama HO: Clinical signifcance of Galectin-3 in clear cell renal cell carcinoma. J Med Invest 2010, 57:152-157
4. Zhang HY, Jin L, Stilling GA, Ruebel KH, Coonse K, Tanizaki Y, Raz A, Lloyd RV: RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors. Endocrine 2009, 35: 101-111
5. Chiu CG, Strugnell SS, Grifth OL, Jones SJ, Gown AM, Walker B, Nabi IR, Wiseman SM: Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol 2010, 176:2067-2081
6. Koo JS, Shin E, Hong SW: Immunohistochemical characteristics of difuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma. APMIS 2010, 118: 744-752
7. Zhu X, Sun T, Lu H, Zhou X, Lu Y, Cai X, Zhu X: Diagnostic signifcance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. J Clin Pathol 2010, 63:786-789
8. Barut F, Onak Kandemir N, Bektas S, Bahadir B, Keser S, Ozdamar SO: Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19. Endocr Pathol 2010, 21:80-89
9. Torregrossa L, Faviana P, Filice ME, Materazzi G, Miccoli P, Vitti P, Fontanini G, Melillo RM, Santoro M, Basolo F: CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1. Tyroid 2010, 20:495-504
10. Saussez S, de Leval L, Decaestecker C, Sirtaine N, Cludts S, Duray A, Chevalier D, André S, Gabius HJ, Remmelink M, Leroy X: Galectin fngerprinting in Warthin's tumors: lectin-based approach to trace its origin? Histol Histopathol 2010, 25:541-550
11. Ersoz S, Sert H, Yandi M, Erem C, Mungan S, Ersoz HO, Cobanoglu U, Hacihasanoglu A: Te signifcance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fne needle aspiration cytology. Pathol Oncol Res 2008, 14:457-460
12. Fassan M, Pennelli G, Pelizzo MR, Rugge M: Primary squamous cell carcinoma of the thyroid: immunohistochemical profle and literature review. Tumori 2007, 93:518-521
13. Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH: Defning a molecular phenotype for benign and malignant parathyroid tumors. Cancer 2009, 115:334-344
14. Saggiorato E, Bergero N, Volante M, Bacillo E, Rosas R, Gasparri G, Orlandi F, Papotti M: Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions. Am J Clin Pathol 2006, 126:59-66
15. Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, Papotti M: Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol 2005, 36:908-914
16. Arfaoui-Toumi A, Kria-Ben Mahmoud L, Ben Hmida M, Khalfallah MT, Regaya-Mzabi S, Bouraoui S: Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients). Bull Cancer 2010, 97:1-8
17. Wu ZH, Gan L: Association of galectin-3 and E-cadherin expressions with lymph node metastasis of colon cancer. Nan Fang Yi Ke Da Xue Xue Bao 2007, 27:1731-1733
18. Huang ZL, Liu HY: Expression of galectin-3 in liver metastasis of colon cancer and the inhibitory efect of modifed citrus pectin Nan Fang Yi Ke Da Xue Xue Bao 2008, 28:1358-1361
19. Miyazaki J, Hokari R, Kato S, Tsuzuki Y, Kawaguchi A, Nagao S, Itoh K, Miura S: Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes. Oncol Rep 2002, 9:1307-1312
20. Zhou JP, Yang ZL, Liu DC, Zhou JP: Expression of galectin 3 and Sambucus nigra agglutinin and their clinicopathological signifcance in benign and malignant lesions of stomach Zhonghua Wei Chang Wai Ke Za Zhi 2009,12:297-300
21. Okada K, Shimura T, Suehiro T, Mochiki E, Kuwano H: Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer. Anticancer Res 2006, 26:1369-1376
22. Yang ZM, Wu XT, He T, Da MX, Luo T, Qian K: Study on association between the expression of galectin-3 and the peritoneal metastasis in gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 2005, 8:151-154
23. Shibata T, Noguchi T, Takeno S, Takahashi Y, Fumoto S, Kawahara K: Impact of nuclear galectin-3 expression on histological diferentiation and vascular invasion in patients with esophageal squamous cell carcinoma. Oncol Rep 2005, 13: 235-239
24. Brazowski E, Dotan I, Tulchinsky H, Filip I, Eisenthal A: Galectin-3 expression in pouchitis in patients with ulcerative colitis who underwent ileal pouch-anal anastomosis (IPAA). Pathol Res Pract 2009, 205:551-558
25. Müller S, Schafer T, Flogerzi B, Fleetwood A, Weimann R, Schoepfer AM, Seibold F: Galectin-3 modulates T cell activity and is reduced in the infamed intestinal epithelium in IBD. Infamm Bowel Dis 2006, 12:588-597
26. Lee JH, Zhang X, Shin BK, Lee ES, Kim I: Mac-2 binding protein and galectin-3 expression in mucinous tumours of the ovary: an annealing control primer system and immunohistochemical study. Pathology 2009, 41:229-233
27. Brustmann H: Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome. Int J Gynecol Pathol 2008, 27:380-389
28. Oishi T, Itamochi H, Kigawa J, Kanamori Y, Shimada M, Takahashi M, Shimogai R, Kawaguchi W, Sato S, Terakawa N: Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary. Int J Gynecol Cancer 2007, 17:1040-1046
29. Devouassoux-Shisheboran M, Deschildre C, Mauduit C, Berger G, Mejean-Lebreton F, Bouvier R, Droz JP, Fénichel P, Benahmed M: Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors. Oncol Rep 2006, 16: 335-340
30. Bozić M, Petronijević M, Milenković S, Atanacković J, Lazić J, Vićovac Lj: Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta 2004, 25:797-802
31. Noël JC, Chapron C, Borghese B, Fayt I, Anaf V: Galectin-3 is overexpressed in various forms of endometriosis. Appl Immunohistochem Mol Morphol 2011, 19:253-257
32. Lee JW, Song SY, Choi JJ, Choi CH, Kim TJ, Kim J, Lee JH, Kim BG, Bae DS: Decreased galectin-3 expression during the progression of cervical neoplasia. J Cancer Res Clin Oncol 2006, 132:241-247
33. Brustmann H: Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions. Int J Gynecol Pathol 2006, 25:30-37
34. Kramer MW, Kuczyk MA, Hennenlotter J, Serth J, Schilling D, Stenzl A, Merseburger AS: Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer. Oncol Rep 2008, 20:1403-1408
35. Merseburger AS, Kramer MW, Hennenlotter J, Serth J, Kruck S, Gracia A, Stenzl A, Kuczyk MA: Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival. World J Urol 2008, 26:637-642
36. Sakaki M, Fukumori T, Fukawa T, Elsamman E, Shiirevnyamba A, Nakatsuji H, Kanayama HO: Clinical signifcance of Galectin-3 in clear cell renal cell carcinoma. J Med Invest 2010, 57:152-157
37. Merseburger AS, Kramer MW, Hennenlotter J, Simon P, Knapp J, Hartmann JT, Stenzl A, Serth J, Kuczyk MA: Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer. Prostate 2008, 68:72-77
38. Wang Y, Nangia-Makker P, Tait L, Balan V, Hogan V, Pienta KJ, Raz A: Regulation of prostate cancer progression by galectin-3. Am J Pathol 2009, 174:1515-1523
39. Ostalska-Nowicka D, Nowicki M, Kondraciuk B, Partyka M, Samulak D, Witt M: Expression of galectin-3 in nephrotic syndrome glomerulopaties in children. Folia Histochem Cytobiol 2009, 47:315-322
40. Park SH, Min HS, Kim B, Myung J, Paek SH: Galectin-3: a useful biomarker for diferential diagnosis of brain tumors. Neuropathology 2008, 28:497-506
41. Borges CB, Bernardes ES, Latorraca EF, Becker AP, Neder L, Chammas R, Roque-Barreira MC, Machado HR, de Oliveira RS: Galectin-3 expression: a useful tool in the diferential diagnosis of posterior fossa tumors in children. Childs Nerv Syst 2011, 27:253-257
42. Rodriguez FJ, Scheithauer BW, Roncaroli F, Silva AI, Kovacs K, Brat DJ, Jin L: Galectin-3 expression is ubiquitous in tumors of the sellar region, nervous system, and mimics: an immunohistochemical and RT-PCR study. Am J Surg Pathol 2008, 32:1344-1352
43. Huang CX, Hou YH, Liu YS: Expression of galectin-3 correlates with apoptosis in pituitary adenoma cells. Neurosci Bull 2008, 24:34-38
44. Jin L, Riss D, Ruebel K, Kajita S, Scheithauer BW, Horvath E, Kovacs K, Lloyd RV: Galectin-3 expression in functioning and silent ACTH-producing adenomas. Endocr Pathol 2005, 16: 107-114
45. Mathieu A, Saal I, Vuckovic A, Ransy V, Vereerstraten P, Kaltner H, Gabius HJ, Kiss R, Decaestecker C, Salmon I, Remmelink M: Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol 2005, 18:1264-1271
46. Pilette C, Colinet B, Kiss R, André S, Kaltner H, Gabius HJ, Delos M, Vaerman JP, Decramer M, Sibille Y: Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD. Eur Respir J 2007, 29:914-922
47. Choi JY, Cho SI, Do NY, Kang CY, Lim SC: Clinical signifcance of the expression of galectin-3 and Pim-1 in laryngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg 2010, 39:28-34
48. Miranda FA, Hassumi MK, Guimarães MC, Simões RT, Silva TG, Lira RC, Rocha AM, Mendes CT Jr, Donadi EA, Soares CP, Soares EG: Galectin-3 overexpression in invasive laryngeal carcinoma, assessed by computer-assisted analysis. J Histochem Cytochem 2009, 57:665-673
49. Chen G, Zou Q, Yang Z: Expression of galectin-3 and Sambucus nigra agglutinin and its clinicopathological signifcance in benign and malignant lesions of breast. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010, 35:584-589
50. Mayoral MA, Mayoral C, Meneses A, Villalvazo L, Guzman A, Espinosa B, Ochoa JL, Zenteno E, Guevara J: Identifcation of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain. Cancer Invest 2008, 26:615-623
51. Fernandez-Aguilar S, Noël JC: Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast. APMIS 2008, 116:33-40
52. D'Haene N, Maris C, Sandras F, Dehou MF, Remmelink M, Decaestecker C, Salmon I: Te diferential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas. Int J Immunopathol Pharmacol 2005, 18:431-443
53. Shimonishi T, Miyazaki K, Kono N, Sabit H, Tuneyama K, Harada K, Hirabayashi J, Kasai K, Nakanuma Y: Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum Pathol 2001, 32:302-310
54. Junking M, Wongkham C, Sripa B, Sawanyawisuth K, Araki N, Wongkham S: Decreased expression of galectin-3 is associated with metastatic potential of liver fuke-associated cholangiocarcinoma. Eur J Cancer 2008, 44:619-626
55. Dechaphunkul A, Kanngurn S, Dechsukhum C, Tanutit P, Khow-Ean U, Sunpaweravong P: Te signifcance of galectin-3 immunohistochemistry, clinical characteristics and liver imaging in diferentiating intrahepatic cholangiocarcinoma from adenocarcinoma liver metastasis. J Med Assoc Tai 2010, 93: 523-528
56. Shen J, Li CD, Yang HL, Lu J, Zou TM, Wang DL, Deng M: Classic chordoma coexisting with benign notochordal cell rest demonstrating diferent immunohistological expression patterns of brachyury and galectin-3. J Clin Neurosci 2011, 18:96-99
57. Alcendor DJ, Knobel SM, Desai P, Zhu WQ, Vigil HE, Hayward GS: KSHV downregulation of galectin-3 in Kaposi's sarcoma. Glycobiology 2010, 20:521-532
58. Bellezza G, Colella R, Sidoni A, Del Sordo R, Ferri I, Cioccoloni C, Cavaliere A: Immunohistochemical expression of Galectin-3 and HBME-1 in granular cell tumors: a new fnding. Histol Histopathol 2008, 23:1127-1130